Anzeige Anzeige: ID Berlin GmbH ×

Economic evaluation of biosimilars for reimbursement purposes - what, when, how? myDRG Stellenmarkt Gesundheitswesen

« Behandlung eines Glioblastoms mit Tumortherapiefeldern wird Kassenleistung | Economic evaluation of biosimilars for reimbursement purposes - what, when, how? | Japan führt Videosprechstunde ein »

 

Economic evaluation of biosimilars for reimbursement purposes - what, when, how?

Economic evaluation of biosimilars for reimbursement purposes - what, when, how? (Taylor & Francis).

Limited previous research and guidelines on the design of economic evaluation for biosimilars have led to unresolved methodological questions on how to assess biosimilars. Objectives: We want to raise awareness...
- - - - - - - -



erschienen am Montag, 13.04.2020
Anzeige Anzeige: ID GmbH ×